Return to content in this issue

Efficacy and Safety of Nemolizumab for Treatment of Adult Atopic Dermatitis: A Meta-analysis of Randomized Clinical Trials

Xiao X^1*, Lin L^1*, Zhu C¹, Yang X¹, Ni Y¹, Zhipeng L¹, Chong J², Han Y<sup>1

1</sup>Department of Dermatology, the Union Hospital, Fujian Medical University, Fuzhou, P.R. China
²College of Materials Science and Engineering, Nanjing Forestry University, Nanjing, P.R. China *These authors contributed to the work equally.

J Investig Allergol Clin Immunol 2021; Vol 31(2) : 190-192
doi: 10.18176/jiaci.0672

• Abstract
• Supplemental Materials

Key words: Nemolizumab, Meta-analysis, Atopic dermatitis, Efficacy, Safety

	Title	Type	Size
	doi10.18176_jiaci.0672_material-suppl_figures_1.pdf	pdf	668.36 Kb
	doi10.18176_jiaci.0672_material-suppl_tables_1.pdf	pdf	208.12 Kb